Company Profile

Novadaq Technologies develops and markets real-time fluorescence imaging technologies for use in the operating room. The company’s primary core technology platform, SPY Imaging, provides clinically relevant, anatomic and physiologic images during open and minimally invasive surgical (MIS) procedures. SPY empowers surgeons to more effectively treat vascular blockages and evaluate anastomotic patency; assess poor or inadequate tissue perfusion; identify cancerous tumors and delineate margins; and visualize relevant lymph nodes for removal during complex operating procedures.  SPY is ideal for use across a variety of surgical specialties such as cardiac, plastic reconstruction and colorectal surgeries. More than 30 peer-reviewed publications have shown that SPY imaging leads to improved clinical outcomes and reduced post-operative complications.  SPY imaging potentially offers a better quality of care and peace of mind to patients who undergo complex operating procedures for the treatment of life-threatening diseases.

The first commercial implementation of SPY imaging called the SPY Imaging System is designed for use during open surgical procedures,  Today, the SPY Imaging System is installed in more than 100 U.S. hospitals.  An endoscopic implementation of SPY imaging (a SPY scope) was cleared by the U.S. Food and Drug Administration in July 2009 for use in MIS. The endoscopic SPY system not only includes SPY imaging capabilities, but also includes state- of- the- art high definition (HD) white light visualization capabilities of a conventional endoscope. Both imaging modes can be viewed simultaneously or separately, depending on physician preference, in real-time during the course of a MIS procedure. In January 2009, Novadaq also announced a technology alliance with Intuitive Surgical Inc., to integrate SPY imaging into the 3-D HD imaging capabilities of the da Vinci® Surgical Robotic System.

The company’s key markets include: cardiac, plastic and reconstructive, upper and lower gastrointestinal, and general surgeries. Novadaq continues to explore further technology alliances for its imaging platforms, particularly in colonoscopic (PINPOINT GI) and ophthamology (OPTTX) applications. The company is also the exclusive United States distributor of PLC Medical’s CO2 HEART LASER System, used in the same cardiac procedures as the SPY System.  

Novadaq is a publicly traded company and is listed on the Toronto Stock Exchange (TSX), under the symbol NDQ.